Baxalta

58 email addresses found for baxalta.com
{first}_{last}@baxalta.com
58 email addresses
http://businesswire.com/news/home/20150804006834/en/baxalta-confirms-receipt-highly-conditional-unsolicited-proposal March 3, 2018
http://businesswire.com/news/home/20151217005076/en/baxalta-present-34th-annual-j.p.-morgan-healthcare March 3, 2018
http://businesswire.com/news/home/20160216005590/en/baxalta-posts-strong-fourth-quarter-2015-sales October 10, 2017
http://catalystportal.co.uk/news/latest_news/shireto_combine_with_baxalta_creating_the_global_leader_in_rare_dise1 July 7, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-pricing-of-secondary-offering-of-common-stock/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-secondary-offering-of-common-stock-owned-by-baxter-international/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-cancels-presentation-at-34th-annual-jp-morgan-healthcare-conference/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-declares-quarterly-dividend/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-to-report-fourth-quarter-and-full-year-2015-results-on-february-16-2016/default.aspx March 3, 2016
http://newsroom.baxalta.com/press-releases/press-release-details/2015/baxalta-confirms-receipt-of-highly-conditional-unsolicited-proposal-from-shire/default.aspx July 7, 2017
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-secondary-offering-of-common-stock/default.aspx July 7, 2017
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-to-report-fourth-quarter-and-full-year-2015-results-on-february-16-2016/default.aspx February 2, 2016
http://presseportal.ch/de/pm/100059179/100782550 September 9, 2017
http://prnewswire.com/news-releases/shire-to-combine-with-baxalta-creating-the-global-leader-in-rare-diseases-564834551.html July 7, 2017
http://prnewswire.co.uk/news-releases/shire-to-combine-with-baxalta-creating-the-global-leader-in-rare-diseases-564834701.html November 11, 2016
http://qlifepro.com/press/20151116-20-25409/il-baxalta-incorporated July 7, 2017
http://qlifepro.com/press/20160525-09-27177/il-baxalta-incorporated-3 May 5, 2017
http://sbcopeninnovation.co.uk/news/latest_news/shireto_combine_with_baxalta_creating_the_global_leader_in_rare_dise1 February 2, 2016
http://benzinga.com/pressreleases/15/11/n5979605/baxalta-to-advance-care-for-hemophilia-a-patients-with-fda-approval-of- May 5, 2017
http://biotech-365.com/baxalta-to-initiate-a-first-in-human-clinical-trial-of-bax-826-an-investigational-extended-half-life-fviii-treatment-targeting-weekly-dosing-for-hemophilia-a May 5, 2016
http://businesswire.com/news/home/20150723005650/en/baxalta-completes-oncaspar-portfolio-acquisition-aims-broaden September 9, 2018
http://businesswire.com/news/home/20150803005068/en/blood-publishes-phase-iii-data-baxalta%e2%80%99s-investigational September 9, 2018
http://businesswire.com/news/home/20160216005590/en/baxalta-posts-strong-fourth-quarter-2015-sales August 8, 2018
http://businesswire.com/news/home/20160225005157/en September 9, 2018
http://businesswire.com/news/home/20160225005157/en/baxalta-precision-biosciences-form-global-genome-editing September 9, 2018
http://checkorphan.org/news/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for-unmet-medical-need-in-myelofibrosis October 10, 2018
http://cnbc.com/2015/10/05/globe-newswire-baxalta-and-momenta-announce-initiation-of-pivotal-clinical-trial-for-m923-a-biosimilar-version-of-humira-adalimumab.html November 11, 2018
http://cnbc.com/2015/11/09/globe-newswire-coherus-and-baxalta-announce-chs-0214-investigational-etanercept-biosimilar-met-primary-efficacy-endpoints-in-phase-3.html September 9, 2018
http://cnbc.com/2016/01/11/globe-newswire-coherus-and-baxalta-announce-chs-0214-investigational-etanercept-biosimilar-met-primary-efficacy-endpoint-in-phase-3.html September 9, 2018
http://eldiariony.com/latinowire/baxalta-supports-research-to-raise-awareness-of-treatment-burden-on-patients-during-the-sixth-annual-world-primary-immunodeficiency-week October 10, 2018
http://ewhv.com/news/detail/baxalta-and-symphogen-establish-strategic-collaboratiion-to-accelerate-inno June 6, 2016
http://fiercebiotech.com/biotech/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for October 10, 2016
http://itespresso.fr/press-release/baxalta-reoit-un-avis-positif-du-chmp-pour-lutilisation-doncaspar-pgaspargase-dans-lunion-europenne-comme-composant-dune-polythrapie-pour-traiter-la-leuceacu May 5, 2017
http://laprensafl.com/latinowire/baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age November 11, 2018
http://media.nektar.com/2015-12-07-baxalta-presents-additional-data-on-newly-approved-adynovate-and-plans-for-new-indications-during-57th-american-society-of-hematology-ash-annual-meeting January 1, 2016
http://media.nektar.com/2015-12-21-baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age January 1, 2016
http://media.nektar.com/2016-04-04-baxalta-expands-global-reach-of-adynovate-for-hemophilia-a-patients-with-approval-in-japan May 5, 2016
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-and-precision-biosciences-form-global-genome-editing-collaboration-in-immuno-oncology/default.aspx July 7, 2017
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-secondary-offering-of-common-stock/default.aspx July 7, 2017
http://precisionbiosciences.com/baxalta-and-precision-biosciences-form-global-genome-editing-collaboration-in-immuno-oncology November 11, 2018
http://prnewswire.com/news-releases/baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age-300195716.html May 5, 2017
http://prnewswire.com/news-releases/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for-unmet-medical-need-in-myelofibrosis-300199090.html July 7, 2017
http://qlifepro.com/press/20151116-20-25409/il-baxalta-incorporated July 7, 2017
http://qlifepro.com/press/20160404-19-26512/il-baxalta-incorporated-2 May 5, 2017
http://qlifepro.com/press/20160525-09-27177/il-baxalta-incorporated-3 May 5, 2017
http://rxtimes.com/baxalta-announces-u-s-availability-of-adynovate-a-new-treatment-for-adult-patients-with-hemophilia-a-with-a-simple-twice-weekly-dosing-schedule August 8, 2016
http://stockguru.com/2016/01/11/coherus-and-baxalta-announce-chs-0214-investigational-etanercept-biosimilar-met-primary-efficacy-endpoint-in-phase-3-rheumatoid-arthritis-clinical-study-rapsody February 2, 2016
http://symphogen.com/2016/01/baxalta-and-symphogen-establish-strategic-collaboration-to-accelerate-innovation-in-immuno-oncology November 11, 2018
http://benzinga.com/pressreleases/15/11/n5979605/baxalta-to-advance-care-for-hemophilia-a-patients-with-fda-approval-of- August 8, 2018
http://biotech-365.com/baxalta-to-initiate-a-first-in-human-clinical-trial-of-bax-826-an-investigational-extended-half-life-fviii-treatment-targeting-weekly-dosing-for-hemophilia-a May 5, 2016
http://businesswire.com/news/home/20150723005650/en/baxalta-completes-oncaspar-portfolio-acquisition-aims-broaden September 9, 2018
http://businesswire.com/news/home/20150803005068/en/blood-publishes-phase-iii-data-baxalta%e2%80%99s-investigational September 9, 2018
http://businesswire.com/news/home/20160216005590/en/baxalta-posts-strong-fourth-quarter-2015-sales August 8, 2018
http://businesswire.com/news/home/20160225005157/en September 9, 2018
http://businesswire.com/news/home/20160225005157/en/baxalta-precision-biosciences-form-global-genome-editing September 9, 2018
http://catalystportal.co.uk/news/latest_news/shireto_combine_with_baxalta_creating_the_global_leader_in_rare_dise1 July 7, 2016
http://checkorphan.org/news/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for-unmet-medical-need-in-myelofibrosis October 10, 2018
http://cnbc.com/2015/10/05/globe-newswire-baxalta-and-momenta-announce-initiation-of-pivotal-clinical-trial-for-m923-a-biosimilar-version-of-humira-adalimumab.html November 11, 2018
http://cnbc.com/2015/11/09/globe-newswire-coherus-and-baxalta-announce-chs-0214-investigational-etanercept-biosimilar-met-primary-efficacy-endpoints-in-phase-3.html September 9, 2018
http://cnbc.com/2016/01/11/globe-newswire-coherus-and-baxalta-announce-chs-0214-investigational-etanercept-biosimilar-met-primary-efficacy-endpoint-in-phase-3.html September 9, 2018
http://eldiariony.com/latinowire/baxalta-supports-research-to-raise-awareness-of-treatment-burden-on-patients-during-the-sixth-annual-world-primary-immunodeficiency-week October 10, 2018
http://ewhv.com/news/detail/baxalta-and-symphogen-establish-strategic-collaboratiion-to-accelerate-inno June 6, 2016
http://futurama5.rssing.com/chan-4084687/all_p38.html September 9, 2018
http://itespresso.fr/press-release/baxalta-reoit-un-avis-positif-du-chmp-pour-lutilisation-doncaspar-pgaspargase-dans-lunion-europenne-comme-composant-dune-polythrapie-pour-traiter-la-leuceacu September 9, 2018
http://laprensafl.com/latinowire/baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age November 11, 2018
http://massbio.org/news/member-news/shire-to-combine-with-baxalta-creating-the-global-leader-in-rare-diseases-65197 May 5, 2016
http://media.nektar.com/2016-04-04-baxalta-expands-global-reach-of-adynovate-for-hemophilia-a-patients-with-approval-in-japan May 5, 2016
http://precisionbiosciences.com/baxalta-and-precision-biosciences-form-global-genome-editing-collaboration-in-immuno-oncology November 11, 2018
http://presseportal.ch/de/pm/100059179/100782550 September 9, 2018
http://presseportal.de/pm/55968/3304613 August 8, 2018
http://prnewswire.com/news-releases/baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age-300195716.html September 9, 2018
http://prnewswire.com/news-releases/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for-unmet-medical-need-in-myelofibrosis-300199090.html September 9, 2018
http://prnewswire.co.uk/news-releases/shire-to-combine-with-baxalta-creating-the-global-leader-in-rare-diseases-564834701.html September 9, 2018
http://rxtimes.com/baxalta-announces-u-s-availability-of-adynovate-a-new-treatment-for-adult-patients-with-hemophilia-a-with-a-simple-twice-weekly-dosing-schedule August 8, 2016
http://shire.com/newsroom/2016/april/publication-of-circular-notice-of-general-meeting-and-prospectus-and-directorate-change September 9, 2016
http://shire.com/newsroom/2016/january/shire-plc-assigned-investment-grade-credit-ratings-by-moodys-and-sandp September 9, 2016
http://symphogen.com/2016/01/baxalta-and-symphogen-establish-strategic-collaboration-to-accelerate-innovation-in-immuno-oncology November 11, 2018
http://tmcnet.com/usubmit/2016/05/23/8367321.htm May 5, 2016
Show more results
48 more results for baxalta.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about baxalta.com

Language of the website: English